Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-26
DOI
10.1007/s12031-020-01537-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod
- (2019) Mohammad Mahdi Eftekharian et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma
- (2019) Tainara F. Felix et al. PLoS One
- The expression levels of miR-655-3p, miR127-5p, miR-369-3p, miR-544a in gastric cancer
- (2019) Hani Alsaadoni et al. Turkish Journal of Biochemistry-Turk Biyokimya Dergisi
- Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs’ World
- (2019) Nicoletta Nuzziello et al. Cells
- Role of miR-449a in the Activation and Metabolism of CD4 + T Cells
- (2018) L. Huang et al. TRANSPLANTATION PROCEEDINGS
- COX-2 induces oncogenic micro RNA miR655 in human breast cancer
- (2018) Mousumi Majumder et al. Scientific Reports
- Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway
- (2017) Chuan Qin et al. STROKE
- Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
- (2017) Jörg Friess et al. Scientific Reports
- MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
- (2016) Gang Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c
- (2016) Qian Wen et al. JOURNAL OF IMMUNOLOGY
- Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis
- (2016) Chiara Fenoglio et al. JOURNAL OF NEUROIMMUNOLOGY
- FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
- (2015) Felix Luessi et al. Multiple Sclerosis Journal
- FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
- (2015) Felix Luessi et al. Multiple Sclerosis Journal
- Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis
- (2013) Chiara Fenoglio et al. Multiple Sclerosis Journal
- Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
- (2008) Åsa Andersson et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started